FI971190A - Solukasvunsäätelijä - Google Patents

Solukasvunsäätelijä Download PDF

Info

Publication number
FI971190A
FI971190A FI971190A FI971190A FI971190A FI 971190 A FI971190 A FI 971190A FI 971190 A FI971190 A FI 971190A FI 971190 A FI971190 A FI 971190A FI 971190 A FI971190 A FI 971190A
Authority
FI
Finland
Prior art keywords
substance
cells
cancer
proliferation
individual
Prior art date
Application number
FI971190A
Other languages
English (en)
Swedish (sv)
Other versions
FI971190A0 (fi
FI113153B (fi
Inventor
Pnina Fishman
Raouf Guirguis
Original Assignee
Can Fite Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Can Fite Technologies Ltd filed Critical Can Fite Technologies Ltd
Publication of FI971190A0 publication Critical patent/FI971190A0/fi
Publication of FI971190A publication Critical patent/FI971190A/fi
Application granted granted Critical
Publication of FI113153B publication Critical patent/FI113153B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI971190A 1994-09-22 1997-03-21 Solukasvunsäätelijä FI113153B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11102194A IL111021A0 (en) 1994-09-22 1994-09-22 Factor derived from muscle cells
PCT/US1995/012093 WO1996009060A1 (en) 1994-09-22 1995-09-22 Cell growth regulator

Publications (3)

Publication Number Publication Date
FI971190A0 FI971190A0 (fi) 1997-03-21
FI971190A true FI971190A (fi) 1997-03-21
FI113153B FI113153B (fi) 2004-03-15

Family

ID=11066570

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971190A FI113153B (fi) 1994-09-22 1997-03-21 Solukasvunsäätelijä

Country Status (17)

Country Link
US (1) US5962331A (fi)
EP (1) EP0782452B1 (fi)
JP (1) JP3778366B2 (fi)
KR (1) KR100392996B1 (fi)
CN (1) CN1146432C (fi)
AT (1) ATE214934T1 (fi)
AU (1) AU692931B2 (fi)
BR (1) BR9509154A (fi)
CA (1) CA2198727C (fi)
DE (1) DE69526096T2 (fi)
DK (1) DK0782452T3 (fi)
ES (1) ES2174963T3 (fi)
FI (1) FI113153B (fi)
IL (2) IL111021A0 (fi)
MX (1) MX9702174A (fi)
RU (1) RU2199327C2 (fi)
WO (1) WO1996009060A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4328897A (en) * 1996-08-23 1998-03-06 Board Of Regents, The University Of Texas System Anti-proliferative factor from transfected cells
IL131096A (en) * 1999-07-26 2004-09-27 Can Fite Technologies Ltd Method for preparing a composition derived from muscle tissue
US20030143282A1 (en) * 2002-01-28 2003-07-31 Pnina Fishman Adenosine A3 receptor agonist
AU2012315956B2 (en) * 2011-09-29 2016-01-21 Seagen Inc. Intact mass determination of protein conjugated agent compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708948A (en) * 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
US5242692A (en) * 1990-07-10 1993-09-07 Bar Ilan University Anti-metastatic factor

Also Published As

Publication number Publication date
FI971190A0 (fi) 1997-03-21
JP3778366B2 (ja) 2006-05-24
CN1164190A (zh) 1997-11-05
FI113153B (fi) 2004-03-15
MX9702174A (es) 1998-04-30
WO1996009060A1 (en) 1996-03-28
RU2199327C2 (ru) 2003-02-27
DK0782452T3 (da) 2002-07-01
IL111021A0 (en) 1994-11-28
CA2198727C (en) 2007-03-27
ATE214934T1 (de) 2002-04-15
JPH10509028A (ja) 1998-09-08
CA2198727A1 (en) 1996-03-28
BR9509154A (pt) 1997-10-14
DE69526096D1 (de) 2002-05-02
EP0782452A1 (en) 1997-07-09
AU692931B2 (en) 1998-06-18
AU3681695A (en) 1996-04-09
KR100392996B1 (ko) 2003-11-28
ES2174963T3 (es) 2002-11-16
CN1146432C (zh) 2004-04-21
DE69526096T2 (de) 2002-09-26
EP0782452B1 (en) 2002-03-27
IL115415A (en) 2001-05-20
US5962331A (en) 1999-10-05
IL115415A0 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
DE3376625D1 (en) Physiological implantable cardiac pacemaker in which the stimulation rate is regulated by the respiration rate of the patient
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
KR970704410A (ko) 암 치료용 종양 세포를 함유하는 이식 장치(Implanted Device Containing Tumor Cells for the Treatment of Cancer)
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
DE68921918D1 (de) Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DK1127355T3 (da) Produkter og fremgangsmpder til brachyterapi
DE69920885D1 (en) C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)"
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
FI971190A (fi) Solukasvunsäätelijä
ATE142499T1 (de) Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
GR3006236T3 (fi)
GR3001850T3 (en) Expellants of phytopathogenic microbes
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
ATE42201T1 (de) Verwendung von phytosterolglycosiden zur herstellung von arzneimitteln zur behandlung von erhoehtem 5(6)alpha-epoxycholesterolgehalt.
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
FR2779844B1 (fr) Structure d'interconnexion entre organes adressables d'un microcalculateur, notamment pour dispositif medical implantable actif tel que stimulateur ou defibrillateur cardiaque
ES499967A0 (es) Un dispositivo de tratamiento corporal electromagnetico parala modificacion quirurgicamente no invasiva del comporta- miento de desarrollo,reparacion y mantenimiento de celulas ytejidos vivos
ATE18989T1 (de) Fixierung von herzklappen-implantatgewebe unter niederdruck.
IT8407212A0 (it) Dispositivo di autocentratura, sostegno e valutazione dell'altezza del paziente per la radiografia dell'intero corpo umano (totalbody) con omografo.
IT8722412A0 (it) Apparecchiatura elettronica per la cura di alterazioni negli organi e nelle funzioni di un organismo.
ES512225A0 (es) "procedimiento y dispositivo correspondiente para el ajuste de un estimulador cardiaco implantable".
MX9700148A (es) Dispositivo implantable que contiene celulas de tumor para el tratamiento del cancer.

Legal Events

Date Code Title Description
MA Patent expired